Gryaznov Sergei 4
4 · MAIA Biotechnology, Inc. · Filed Apr 30, 2024
Insider Transaction Report
Form 4
Gryaznov Sergei
Chief Scientific Officer
Transactions
- Award
Stock Options
2024-04-26+141,000→ 141,000 totalExercise: $2.94Exp: 2034-04-26→ Common Stock (141,000 underlying)
Footnotes (1)
- [F1]The stock options, granted on April 26, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversay of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months.